Shimmer, looks like investors are finally seeing the stock is a true and valid investment where this market cap will ignite and boutique funds are getting involved. The small holders are likely to sell their $1000.00 holdings and the long term like me are awaiting the $12+ share price. When will that happen? Fk knows.
Pharma is a waiting game and a game that can see enormous returns or the opposite.
We are looking good for positive gains and I have always said for 10 years, once we have over 100 buyers, that’s when this baby will ignite and offer a significant increase to the share price.
I’m dealing with several buyers in the Pharma space On a different business I’m involved in and suggest we are very close to a deal with management involved as the Pharma space right now is HOT!
hold em tight. Hold these very tight!
Ill be putting the stickers on the NEU boat soon. It’s been a fk long wait......
- Forums
- ASX - By Stock
- NEU
- Ann: 2019 year-end update and 2020 outlook
Ann: 2019 year-end update and 2020 outlook, page-114
-
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$13.18 |
Change
-0.430(3.16%) |
Mkt cap ! $1.684B |
Open | High | Low | Value | Volume |
$13.64 | $13.67 | $13.18 | $8.868M | 666.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 5233 | $13.18 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.24 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 5233 | 13.180 |
1 | 2135 | 13.170 |
2 | 1561 | 13.160 |
1 | 2135 | 13.150 |
3 | 2356 | 13.130 |
Price($) | Vol. | No. |
---|---|---|
13.240 | 1000 | 1 |
13.290 | 3819 | 3 |
13.300 | 2000 | 1 |
13.310 | 2135 | 1 |
13.340 | 2135 | 1 |
Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
Featured News
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
NEU (ASX) Chart |
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
SPONSORED BY The Market Online